Activation of the renin–angiotensin system within podocytes in diabetes

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.5K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

Edmund J. Lewis, Lawrence G. Hunsicker, Raymond P. Bain et al. · New England Journal of Medicine · 1993 · 5.4K citations

Medicine, Nephrology, Pharmacology +13

The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C

Dominique Toullec, P. Pianetti, Hervé Coste et al. · Journal of Biological Chemistry · 1991 · 2.5K citations · Full text

Pharmacy, Biochemistry, Pharmacology +11

Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C

Eiji Kobayashi, Hirofumi Nakano, Makoto Morimoto et al. · Biochemical and Biophysical Research Communications · 1989 · 1.1K citations

Life Sciences, Biochemistry, Medicinal Chemistry +9

Podocyte loss and progressive glomerular injury in type II diabetes.

Maria Enrica Pagtalunan, Paul L. Miller, S Jumping-Eagle et al. · Journal of Clinical Investigation · 1997 · 1.1K citations · Full text

Medicine, Nephrology, Pathology +17